MBXBF
Price
$0.21
Change
-$0.01 (-4.55%)
Updated
Jul 24 closing price
Capitalization
30.07M
NDTP
Price
$0.06
Change
+$0.01 (+20.00%)
Updated
Jul 21 closing price
Capitalization
9.76M
Interact to see
Advertisement

MBXBF vs NDTP

Header iconMBXBF vs NDTP Comparison
Open Charts MBXBF vs NDTPBanner chart's image
Microbix Biosystems
Price$0.21
Change-$0.01 (-4.55%)
Volume$100K
Capitalization30.07M
NDT Pharmaceuticals
Price$0.06
Change+$0.01 (+20.00%)
Volume$12.53K
Capitalization9.76M
MBXBF vs NDTP Comparison Chart in %
Loading...
MBXBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NDTP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MBXBF vs. NDTP commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MBXBF is a Hold and NDTP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (MBXBF: $0.21 vs. NDTP: $0.06)
Brand notoriety: MBXBF and NDTP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MBXBF: 438% vs. NDTP: 219%
Market capitalization -- MBXBF: $30.07M vs. NDTP: $9.76M
MBXBF [@Biotechnology] is valued at $30.07M. NDTP’s [@Biotechnology] market capitalization is $9.76M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MBXBF’s FA Score shows that 1 FA rating(s) are green whileNDTP’s FA Score has 1 green FA rating(s).

  • MBXBF’s FA Score: 1 green, 4 red.
  • NDTP’s FA Score: 1 green, 4 red.
According to our system of comparison, both MBXBF and NDTP are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MBXBF’s TA Score shows that 3 TA indicator(s) are bullish while NDTP’s TA Score has 2 bullish TA indicator(s).

  • MBXBF’s TA Score: 3 bullish, 4 bearish.
  • NDTP’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, MBXBF is a better buy in the short-term than NDTP.

Price Growth

MBXBF (@Biotechnology) experienced а -2.33% price change this week, while NDTP (@Biotechnology) price change was +17.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.62%. For the same industry, the average monthly price growth was +17.39%, and the average quarterly price growth was +28.36%.

Reported Earning Dates

MBXBF is expected to report earnings on May 15, 2025.

Industries' Descriptions

@Biotechnology (+7.62% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MBXBF($30.1M) has a higher market cap than NDTP($9.76M). NDTP YTD gains are higher at: 15.094 vs. MBXBF (-26.021).
MBXBFNDTPMBXBF / NDTP
Capitalization30.1M9.76M308%
EBITDA4.35MN/A-
Gain YTD-26.02115.094-172%
P/E Ratio26.44N/A-
Revenue22.7MN/A-
Total Cash14.5MN/A-
Total Debt5.35MN/A-
FUNDAMENTALS RATINGS
MBXBF vs NDTP: Fundamental Ratings
MBXBF
NDTP
OUTLOOK RATING
1..100
2449
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
5
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
82100
PRICE GROWTH RATING
1..100
8497
P/E GROWTH RATING
1..100
8100
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NDTP's Valuation (5) in the null industry is significantly better than the same rating for MBXBF (77). This means that NDTP’s stock grew significantly faster than MBXBF’s over the last 12 months.

NDTP's Profit vs Risk Rating (100) in the null industry is in the same range as MBXBF (100). This means that NDTP’s stock grew similarly to MBXBF’s over the last 12 months.

MBXBF's SMR Rating (82) in the null industry is in the same range as NDTP (100). This means that MBXBF’s stock grew similarly to NDTP’s over the last 12 months.

MBXBF's Price Growth Rating (84) in the null industry is in the same range as NDTP (97). This means that MBXBF’s stock grew similarly to NDTP’s over the last 12 months.

MBXBF's P/E Growth Rating (8) in the null industry is significantly better than the same rating for NDTP (100). This means that MBXBF’s stock grew significantly faster than NDTP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MBXBFNDTP
RSI
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
29%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
45%
Momentum
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
70%
MACD
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
51%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
65%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
47%
Advances
ODDS (%)
Bullish Trend 10 days ago
65%
N/A
Declines
ODDS (%)
Bearish Trend 12 days ago
70%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
54%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
MBXBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NDTP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NTLA13.600.82
+6.38%
Intellia Therapeutics
CSCO68.690.40
+0.59%
Cisco Systems
TRUE1.960.01
+0.51%
TrueCar
GIL52.25-0.88
-1.66%
Gildan Activewear
HYMC3.58-0.11
-2.98%
Hycroft Mining Holding Corp

MBXBF and

Correlation & Price change

A.I.dvisor tells us that MBXBF and CRMD have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MBXBF and CRMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBXBF
1D Price
Change %
MBXBF100%
N/A
CRMD - MBXBF
27%
Poorly correlated
-0.09%
TECX - MBXBF
23%
Poorly correlated
+0.18%
BVNKF - MBXBF
21%
Poorly correlated
-2.18%
NBY - MBXBF
20%
Poorly correlated
+3.23%
MMIRF - MBXBF
15%
Poorly correlated
N/A
More

NDTP and

Correlation & Price change

A.I.dvisor tells us that NDTP and MAIA have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NDTP and MAIA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NDTP
1D Price
Change %
NDTP100%
N/A
MAIA - NDTP
21%
Poorly correlated
-0.58%
MMIRF - NDTP
11%
Poorly correlated
N/A
MBXBF - NDTP
7%
Poorly correlated
N/A
NGENF - NDTP
6%
Poorly correlated
-4.44%
MEOBF - NDTP
4%
Poorly correlated
N/A
More